Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study

OBJECTIVES: Gastrointestinal (GI) involvement in myositis is a severe extra muscular manifestation with potentially life-threatening outcomes. However, it remains poorly characterized. We aimed to evaluate the prevalence of GI involvement in dermatomyositis (DM) and to describe its characteristics in anti-NXP2 DM. METHODS: The prevalence of GI involvement across DM subgroups was assessed in a retrospective monocentric DM cohort (n = 119). It was further investigated in a retrospective multicentric cohort of anti-NXP2 DM (n = 48). GI involvement (defined as any symptomatic GI lesion, excluding isolated dysphagia) was considered severe when requiring surgery and/or intensive care unit admission. RESULTS: In the monocentric DM cohort, severe GI involvement was observed in 18% of anti-NXP2 patients and 6% of anti-MDA5 patients. Severe GI involvement was significantly more frequent in anti-NXP2 patients compared with other DM subgroups (hazard ratio 8.85 [95% CI 1.62-48.35]). In the multicentric anti-NXP2 cohort, severe GI involvement (including four digestive perforations and three digestive haemorrhages) occurred in 12.5% of patients. Anti-NXP2 patients with severe GI involvement were significantly younger (median age 24.5 vs 42.5 years; p< 0.01) and more frequently presented with facial oedema at diagnosis (83% vs 33%; p= 0.03). At the time of GI involvement, 78% of anti-NXP2 patients had concomitant skin and/or muscle disease activity. No deaths were reported. CONCLUSION: Severe GI involvement represents a life-threatening complication in DM and is mainly associated with anti-NXP2 antibody. In anti-NXP2 DM, young age and facial oedema are associated with severe GI involvement.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2026-06-17
DOI
https://doi.org/10.1093/rheumatology/keag282
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study

Luc Mouthon, Eric HACHULLA, Yves Allenbach, Olivier Benvéniste et al.
Lara D. Veeken
Inflammatory Myopathies and Dermatomyositis
article

Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study

Luc Mouthon, Eric HACHULLA, Yves Allenbach, Olivier Benvéniste, Delphine Larivière, Alain Meyer, D. Staumont‐Sallé, Nicolas Limal, Laure Gallay, Laurent Gilardin, Sarah Léonard-Louis, C. Fite, Valérie Jooste, Nathalie Costedoat-Chalumeau, Solal Bellaiche, Mohamed-Yacine Khitri, Anne‐Marie Bouvier, A Bardier, Benoît Gachet, Benjamin Terrier, Stephane Vinzio, Jean Luc Charuel, Camille Rasmussen, Yoann Crabol, Juliette Avci, S. Tayb-Boulahfa, Jean Baptiste Noury, Orane Demuynck
article en

Abstract

OBJECTIVES: Gastrointestinal (GI) involvement in myositis is a severe extra muscular manifestation with potentially life-threatening outcomes. However, it remains poorly characterized. We aimed to evaluate the prevalence of GI involvement in dermatomyositis (DM) and to describe its characteristics in anti-NXP2 DM. METHODS: The prevalence of GI involvement across DM subgroups was assessed in a retrospective monocentric DM cohort (n = 119). It was further investigated in a retrospective multicentric cohort of anti-NXP2 DM (n = 48). GI involvement (defined as any symptomatic GI lesion, excluding isolated dysphagia) was considered severe when requiring surgery and/or intensive care unit admission. RESULTS: In the monocentric DM cohort, severe GI involvement was observed in 18% of anti-NXP2 patients and 6% of anti-MDA5 patients. Severe GI involvement was significantly more frequent in anti-NXP2 patients compared with other DM subgroups (hazard ratio 8.85 [95% CI 1.62-48.35]). In the multicentric anti-NXP2 cohort, severe GI involvement (including four digestive perforations and three digestive haemorrhages) occurred in 12.5% of patients. Anti-NXP2 patients with severe GI involvement were significantly younger (median age 24.5 vs 42.5 years; p< 0.01) and more frequently presented with facial oedema at diagnosis (83% vs 33%; p= 0.03). At the time of GI involvement, 78% of anti-NXP2 patients had concomitant skin and/or muscle disease activity. No deaths were reported. CONCLUSION: Severe GI involvement represents a life-threatening complication in DM and is mainly associated with anti-NXP2 antibody. In anti-NXP2 DM, young age and facial oedema are associated with severe GI involvement.

Lara D. Veeken
Université Libre de Bruxelles (BE), Inserm (FR), Université de Bourgogne (FR), Université Paris-Est Créteil (FR), Université Paris Cité (FR), Aix-Marseille Université (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Lille’s Cardiology Hospital (FR), Hôpital Cochin (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Centre hospitalier Bretagne Atlantique (FR), Laboratoire National de Référence (MA), Groupe Hospitalier Mutualiste de Grenoble (FR), Institut de Myologie (FR), Centre Hospitalier de Tourcoing (FR), CHU Dijon Bourgogne (FR), Hôpital Saint Joseph (FR), Pitié-Salpêtrière Hospital (FR), Laboratoire des Sciences et Techniques de l’Information de la Communication et de la Connaissance (FR), Centre Hospitalier Régional Universitaire de Brest (FR), Hôpitaux Universitaires de Strasbourg (FR), Hôpital Jean-Verdier (FR), Hôpital Foch (FR)
Good health and well-being
Openalex Percentile: Top 7%
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.